JPRN-UMIN000000929已完成2 期
Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601) - Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 422 人开始时间: 2007年12月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 422
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)anamnesis of graucoma (2)diabetes mellitus treating insulin or uncontrolled (3)uncontrollable hypertension (4)coronary artery necessary, cardiomyopathy and heart failure necessary treatment, arrhythmia treating antiarrhyshmic (5)HBs-Ag positive (6)HCV positive (7)HIV positive (8)interstitial pneumonia, plumonary fiblosis (9)severe infection (10)synchronous or metachronous malignancy (11)pregnant/lactating woman (12)psychosis (13)given systemic steroid
研究者
相似试验
进行中（未招募）
不适用
An Open-label, Randomized, Phase 2 Study of R-CHOP Plus Enzastaurin versus R-CHOP in the First-Line Treatment of Patients with Intermediate and High-Risk Diffuse Large B-Cell Lymphoma - N/AFirst-Line Diffuse Large B-Cell LymphomaMedDRA version: 9.1Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)EUCTR2008-005496-10-IEEli Lilly and Company100
进行中（未招募）
1 期
Randomized phase II study of treatment with R-CHOP vs Bortezomib-R-CAP for young patients with poor IPI diffuse large B-cell lymphoma.EUCTR2012-005138-12-ESGELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea)127
已完成
2 期
Randomized phase II study of biweekly R-CHOP versus biweekly R-CHOP followed by CHASER as induction therapy for high-dose chemotherapy, LEED, and autologous stem-cell transplantation in poor-risk diffuse large B-cell lymphoma (JCOG0908, DLBCL-bi-R-CHOP/CHASER-LEED-rP2 )diffuse large B-cell lymphoma, including subtypeslymphomatoid granulomatosis, grade 3primary mediastinal (thymic) large B-cell lymphomaJPRN-UMIN000003823Japan Clinical Oncology Group (JCOG)70
进行中（未招募）
1 期
A trial of CHOP-R therapy with or without acalabrutinib in patients with newly diagnosed Richter's SyndromeEUCTR2017-004401-40-GBniversity of Birmingham105
进行中（未招募）
不适用
A phase II study of R-CHOP with intensive CNS prophylaxis and scrotal irradiation in patients with primary testicular diffuse large B-cell lymphoma - IELSG30EUCTR2009-011789-26-ITIELSG-International Extranodal Lymphoma Study Group35